Business / Finance

RSS

Globavir agrees to exclusively license novel oncology compound to Sorrento Therapeutics

Globavir Biosciences, Inc., a specialty biotechnology company developing small molecule drugs to treat cancer and infectious diseases, and Sorrento Therapeutics, Inc., an oncology company developing new treatments for cancer and associated pain, announced today that the companies have entered into an agreement under which Globavir exclusively licensed its novel oncology compound, BC001, to Sorrento Therapeutics.

9 Jul 2015

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

Sorrento Therapeutics, Inc. and NantBioScience, Inc., a majority owned subsidiary of NantWorks, LLC, announced today that they have established a joint venture to focus on the development of 'first-in-class' small molecules against targets that have eluded the pharmaceutical industry to date and which may address important drivers of cancer growth including cancer stem cells.

9 Jul 2015

EvoRx Technologies, AstraZeneca successfully complete research collaboration

AstraZeneca and EvoRx Technologies successfully completed a one-year research collaboration leveraging EvoRx's proprietary Evo-Link technology to discover cell penetrating peptides for a high value intracellular protein–protein interaction target in the respiratory portfolio.

9 Jul 2015

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases, announced today that it has entered into a Research, Option and License Agreement ("License Agreement") and a Share Purchase Agreement with One Way Liver Genomics S.L., for the development of a non-invasive, blood-based companion diagnostic tool.

8 Jul 2015

Resverlogix and Hepalink close license agreement, sign definitive stock purchase agreement

Resverlogix Corp. announced today that it has closed a license agreement and formally entered into a definitive stock purchase agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd..

8 Jul 2015

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Immune Pharmaceuticals, Inc. announced today that it has amended its 2003 Licensing Agreement with Endo Pharmaceuticals Inc., a subsidiary of Endo International plc. As a result, Immune will transfer to Endo its previously licensed patents related to the use of topical lidocaine in acute and chronic back pain and Endo will grant Immune a royalty-free, non-exclusive, fully transferable license to those patents.

8 Jul 2015

Smith & Nephew becomes exclusive distributor of Scopis TGS system in UK, Ireland and Belgium

Smith & Nephew plc, the global medical technology business, today announces a partnership with ScopisGmbH, the German developer and manufacturer of surgical navigation systems, as the exclusive distributor of Scopis TGS Target Guided Surgery system in the UK, Ireland and Belgium from 1 July.

8 Jul 2015

NCC of South Korea, Velos agree to expand use of Velos eResearch for cancer research

The National Cancer Center of South Korea and Velos, Inc. have entered into a seven year agreement to expand the use of Velos eResearch for cancer research nationally throughout South Korea and internationally in collaboration with other research partners.

7 Jul 2015

Aytu BioScience now trading under new symbol following its corporate name change

Aytu BioScience, Inc., a specialty healthcare company focused on developing treatments for urological and related conditions, announced today that the company is now trading under the new symbol "AYTU," following its corporate name change, which became effective June 8, 2015.

7 Jul 2015

EnteroMedics prices previously announced public offering of 32,000,000 units

EnteroMedics Inc., a developer and manufacturer of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders, announced the pricing of its previously announced public offering of 32,000,000 units.

7 Jul 2015

Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. for approximately US$72.6 million.

From Mindray 7 Jul 2015

Bionik Laboratories successfully raises US$13.1 million in private placement transaction

Bionik Laboratories Corp., a medical device and robotics company with a core focus in robotic exoskeleton technology for users with mobility impairments, announced today that it has completed an additional sale to qualified accredited investors of units consisting of its common stock and warrants for aggregate gross proceeds of approximately US$1.4 million in a private placement transaction.

7 Jul 2015

Hi-Tech enters into definitive agreement to acquire Innovative's brand of Diet Aids

Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition, Weight loss products, and Contract Manufacturing services, and Innovative laboratories, one of the fastest-growing Weight Loss brands in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire Innovative's brand of Diet Aids.

7 Jul 2015

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Allergan plc and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck's investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR).

7 Jul 2015

Leica DM2500 LED Microscope for clinical laboratories and research applications launched by Leica Microsystems

With the launch of the Leica DM2500 LED, Leica Microsystems completes its Leica DM1000 to 3000 series of microscopes. All the models in this series are now available with LED illumination. The Leica DM2500 LED is suitable for demanding tasks in clinical laboratories as well as for research applications in microbiology, developmental biology, cytology, zoology, botany, and more.

From Leica Microsystems GmbH 6 Jul 2015

Allergan enters into agreement to acquire Oculeve

Allergan plc, a leading global pharmaceutical company, and Oculeve, a development-stage medical device company focused on developing novel treatments for dry eye disease, today announced that they have entered into an agreement under which Allergan will acquire Oculeve in an all-cash transaction.

6 Jul 2015

Zecotek provides shareholders with corporate update on 3D display and 3D printing technologies

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, is pleased to provide shareholders with a corporate update on its path to commercialize its leading-edge 3D display and 3D printing technologies.

6 Jul 2015

TSO3 forms wholly owned subsidiary to meet US customer requirements

TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced the formation of a wholly owned subsidiary: TSO3 Corporation, structured under the laws of the State of Delaware, and located in the State of South Carolina, USA.

6 Jul 2015

Redwood Pharma signs licensing agreement with Broda Technologies for hydrogel drug delivery technology

Redwood Pharma AB has entered into a licensing agreement with Broda Technologies Co., Ltd., operating in both the US and China, to use the company's proprietary IntelliGel supramolecular hydrogel technology in its lead chronic Dry Eye therapeutic currently under development and other ophthalmic therapies.

3 Jul 2015

Konica Minolta announces acquisition of Sawae Technologica

Konica Minolta, Inc. today announced that it has acquired Sawae Technologica Ltda., an X-ray system equipment manufacturer based in Minas Gerais, Brazil, through its Brazilian healthcare sales company, Konica Minolta Healthcare do Brazil.

2 Jul 2015

Business / Finance

Globavir agrees to exclusively license novel oncology compound to Sorrento Therapeutics

Sorrento, NantBioScience form joint venture to develop targeted therapies against cancer

EvoRx Technologies, AstraZeneca successfully complete research collaboration

Galmed signs License Agreement for development of blood-based companion diagnostic tool

Resverlogix and Hepalink close license agreement, sign definitive stock purchase agreement

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Smith & Nephew becomes exclusive distributor of Scopis TGS system in UK, Ireland and Belgium

NCC of South Korea, Velos agree to expand use of Velos eResearch for cancer research

Aytu BioScience now trading under new symbol following its corporate name change

EnteroMedics prices previously announced public offering of 32,000,000 units

Mindray announces definitive agreement to acquire remaining stake in Dragonbio for US$72.6 million

Bionik Laboratories successfully raises US$13.1 million in private placement transaction

Hi-Tech enters into definitive agreement to acquire Innovative's brand of Diet Aids

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Leica DM2500 LED Microscope for clinical laboratories and research applications launched by Leica Microsystems

Allergan enters into agreement to acquire Oculeve

Zecotek provides shareholders with corporate update on 3D display and 3D printing technologies

TSO3 forms wholly owned subsidiary to meet US customer requirements

Redwood Pharma signs licensing agreement with Broda Technologies for hydrogel drug delivery technology

Konica Minolta announces acquisition of Sawae Technologica

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News